Who’s Hired? Stada Appoints New UK Head
Amneal And Mayne Also Make Major New Appointments
Executive Summary
Summer’s end brings notable leadership reshuffles across four continents and five companies. Stada has appointed its head of mid-sized European markets as its UK lead while Gustavo Pesquin joins Amneal from Sanofi.
You may also be interested in...
Adcock Kept Cash Back For Two Major Deals, Prioritizes Partnerships
Adcock Ingram intends to continue seeking partnership deals with multinational firms, after failing to complete two significant acquisitions during its financial year ended 30 June 2022.
Stada Enjoys Robust First Half For Generics And Biosimilars
With generics and biosimilars sales continuing to flow in the first half of 2022, Stada reported healthy top- and bottom-line growth for the first six months of the year, including a 23% rise for its adjusted EBITDA.
Mayne Pharma CEO Steps Down Amid $475m Metrics Contract Services Sale
Significant change is brewing at Mayne Pharma, with the Australian firm announcing the proposed sale of its US-based CDMO business for nearly half-a-billion dollars. At the same time, long time CEO Scott Richards is heading for the exit door.